PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 185 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $10,463,000 | +94.2% | 581,600 | -23.0% | 0.03% | +47.6% |
Q1 2020 | $5,389,000 | -37.3% | 755,800 | +110.1% | 0.02% | +5.0% |
Q4 2019 | $8,590,000 | -7.9% | 359,700 | +3.4% | 0.02% | -13.0% |
Q3 2019 | $9,328,000 | +45.6% | 347,800 | +47.3% | 0.02% | +43.8% |
Q2 2019 | $6,405,000 | +724.3% | 236,100 | +892.0% | 0.02% | +700.0% |
Q1 2018 | $777,000 | -95.5% | 23,800 | -93.3% | 0.00% | -95.7% |
Q4 2017 | $17,315,000 | +66.1% | 355,700 | +84.4% | 0.05% | +56.7% |
Q3 2017 | $10,422,000 | +21.0% | 192,900 | +25.8% | 0.03% | +7.1% |
Q2 2017 | $8,616,000 | +1501.5% | 153,391 | +1016.7% | 0.03% | +1300.0% |
Q1 2017 | $538,000 | -61.0% | 13,736 | -76.5% | 0.00% | -71.4% |
Q2 2016 | $1,381,000 | +27.8% | 58,500 | +10.4% | 0.01% | +16.7% |
Q1 2016 | $1,081,000 | +60.4% | 53,000 | +304.6% | 0.01% | +50.0% |
Q4 2015 | $674,000 | +105.5% | 13,100 | +70.1% | 0.00% | +100.0% |
Q3 2015 | $328,000 | -34.5% | 7,700 | -30.0% | 0.00% | -50.0% |
Q2 2015 | $501,000 | -71.6% | 11,000 | -76.3% | 0.00% | -71.4% |
Q1 2015 | $1,761,000 | +522.3% | 46,400 | +364.0% | 0.01% | +600.0% |
Q4 2014 | $283,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |